These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26722766)

  • 61. Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: the ZABTON-PC (zoledronic acid/androgen blockade trial on prostate cancer) study.
    Ueno S; Mizokami A; Fukagai T; Fujimoto N; Oh-Oka H; Kondo Y; Arai G; Ide H; Horie S; Ueki O; Kawaguchi K; Shimamura M; Orito M; Ishida T; Ikeda D; Namiki M
    Anticancer Res; 2013 Sep; 33(9):3837-44. PubMed ID: 24023317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States.
    Stopeck A; Rader M; Henry D; Danese M; Halperin M; Cong Z; Qian Y; Dansey R; Chung K
    J Med Econ; 2012; 15(4):712-23. PubMed ID: 22409231
    [TBL] [Abstract][Full Text] [Related]  

  • 63. N-Telopeptide of Type I Collagen Long-Term Dynamics in Breast Cancer Patients With Bone Metastases: Clinical Outcomes and Influence of Extraskeletal Metastases.
    Ferreira AR; Alho I; Shan N; Matias M; Faria M; Casimiro S; Leitzel K; Ali S; Lipton A; Costa L
    Oncologist; 2016 Dec; 21(12):1418-1426. PubMed ID: 27534575
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
    Lipton A
    Breast Cancer Res Treat; 2010 Aug; 122(3):627-36. PubMed ID: 20490653
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
    Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
    Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?
    Steinman RA; Brufsky AM; Oesterreich S
    Breast Cancer Res; 2012 Sep; 14(5):213. PubMed ID: 23014660
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Breast-cancer adjuvant therapy with zoledronic acid.
    Coleman RE; Marshall H; Cameron D; Dodwell D; Burkinshaw R; Keane M; Gil M; Houston SJ; Grieve RJ; Barrett-Lee PJ; Ritchie D; Pugh J; Gaunt C; Rea U; Peterson J; Davies C; Hiley V; Gregory W; Bell R;
    N Engl J Med; 2011 Oct; 365(15):1396-405. PubMed ID: 21995387
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid.
    Shah SR; Jean GW; Keisner SV; Ussery SM; Dowell JE
    Support Care Cancer; 2012 Jan; 20(1):87-93. PubMed ID: 21197550
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Zoledronic acid in the treatment of early-stage breast cancer: is there a final verdict?
    Gnant M
    Curr Oncol Rep; 2012 Feb; 14(1):35-43. PubMed ID: 22113793
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis.
    Ben-Aharon I; Vidal L; Rizel S; Yerushalmi R; Shpilberg O; Sulkes A; Stemmer SM
    PLoS One; 2013; 8(8):e70044. PubMed ID: 23990894
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis.
    Jackson C; Freeman ALJ; Szlamka Z; Spiegelhalter DJ
    PLoS One; 2021; 16(2):e0246441. PubMed ID: 33544765
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bisphosphonates Versus Denosumab for Prevention of Pathological Fracture in Advanced Cancers With Bone Metastasis: A Meta-analysis of Randomized Controlled Trials.
    Al Farii H; Frazer A; Farahdel L; AlFayyadh F; Turcotte R
    J Am Acad Orthop Surg Glob Res Rev; 2020 Aug; 4(8):e20.00045. PubMed ID: 32769706
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer.
    Aft RL; Naughton M; Trinkaus K; Weilbaecher K
    Br J Cancer; 2012 Jun; 107(1):7-11. PubMed ID: 22617128
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term outcome of (neo)adjuvant zoledronic acid therapy in locally advanced breast cancer.
    Jallouk AP; Paravastu S; Weilbaecher K; Aft RL
    Breast Cancer Res Treat; 2021 May; 187(1):135-144. PubMed ID: 33591469
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis.
    Wang Y; He L; Song Y; Wu Q; Wang H; Zhang B; Ma X
    BMC Womens Health; 2020 Jan; 20(1):17. PubMed ID: 32005117
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis.
    Li Y; Yang D; Chen P; Yin X; Sun J; Li H; Ren G
    Aging (Albany NY); 2019 Aug; 11(16):6286-6311. PubMed ID: 31446432
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The efficacy and safety of zoledronic acid and strontium-89 in treating non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials.
    Hu Z; Tian Y; Li W; Ruan Y; Zeng F
    Support Care Cancer; 2020 Jul; 28(7):3291-3301. PubMed ID: 31754835
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Routine use of zoledronic acid in early-stage breast cancer.
    Harnden K; Blackwell K
    J Natl Compr Canc Netw; 2015 Apr; 13(4):480-6. PubMed ID: 25870382
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Zoledronic acid as an adjuvant therapy in patients with breast cancer: a systematic review and meta-analysis.
    Huang WW; Huang C; Liu J; Zheng HY; Lin L
    PLoS One; 2012; 7(7):e40783. PubMed ID: 22844410
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of zoledronic acid on type and volume of Modic changes among patients with low back pain.
    Koivisto K; Järvinen J; Karppinen J; Haapea M; Paananen M; Kyllönen E; Tervonen O; Niinimäki J
    BMC Musculoskelet Disord; 2017 Jun; 18(1):274. PubMed ID: 28645291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.